HXBM logo

Helix BioMedix, Inc. Stock Price

OTCPK:HXBM Community·US$606.7k Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

HXBM Share Price Performance

US$2.70
-4.49 (-62.45%)
US$2.70
-4.49 (-62.45%)
Price US$2.70

HXBM Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

Helix BioMedix, Inc. Key Details

US$2.1m

Revenue

US$641.2k

Cost of Revenue

US$1.4m

Gross Profit

US$4.0m

Other Expenses

-US$2.6m

Earnings

Last Reported Earnings
Sep 30, 2012
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About HXBM

Founded
1988
Employees
n/a
CEO
Robin Carmichael
WebsiteView website
www.helixbiomedix.com

Helix BioMedix, Inc., a biotechnology company, develops peptide-based therapeutics for dermatology and skin health in the United States. It is developing HB4208 for treatment of the rare disease Xeroderma Pigmentosum; and BIOACTIVE SMARTPEPTIDES, a bioactive peptide ingredient for skin care companies. The company was founded in 1988 and is based in Bothell, Washington.

Recent HXBM News & Updates

No updates

Recent updates

No updates